NexImmune Balance Sheet Health
Financial Health criteria checks 6/6
NexImmune has a total shareholder equity of $3.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.6M and $5.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.20m |
| Equity | US$3.51m |
| Total liabilities | US$5.08m |
| Total assets | US$8.59m |
Recent financial health updates
Recent updates
NexImmune (NASDAQ:NEXI) Will Have To Spend Its Cash Wisely
Sep 07
Neximmune GAAP EPS of -$0.69 misses by $0.01
Aug 15NexImmune gains aftermarket on IND clearance for NEXI-003 to treat HPV-related cancers
Jul 14NexImmune: Selling For Under Cash Value
May 31Here's Why We're A Bit Worried About NexImmune's (NASDAQ:NEXI) Cash Burn Situation
May 26We're Keeping An Eye On NexImmune's (NASDAQ:NEXI) Cash Burn Rate
Dec 19Financial Position Analysis
Short Term Liabilities: NEXI's short term assets ($5.4M) exceed its short term liabilities ($5.1M).
Long Term Liabilities: NEXI has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NEXI is debt free.
Reducing Debt: NEXI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NEXI has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: NEXI is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.